Cliff Asness's PBH Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 24,116 shares of Prestige Consumer Healthcare Inc. (PBH) worth $1.49 M, representing 0.00% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in PBH, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 247,001 shares. Largest reduction occurred in Q1 2021, reducing 298,900 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Prestige Consumer Healthcare (PBH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Prestige Consumer Healthcare (PBH) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2012 | +239,143 | Add 0.00% | 239,142 | $20.03 |
| Q2 2013 | +246,743 | Add 0.00% | 246,742 | $29.14 |
| Q3 2013 | -116,891 | Reduce 47.37% | 129,851 | $30.12 |
| Q4 2013 | -16,900 | Reduce 13.01% | 112,951 | $35.80 |
| Q1 2014 | -49,200 | Reduce 43.56% | 63,751 | $27.25 |
| Q2 2014 | -42,509 | Reduce 66.68% | 21,242 | $33.90 |
| Q3 2014 | +1,600 | Add 7.53% | 22,842 | $32.35 |
| Q4 2014 | -22,842 | Sold Out | 22,842 | $0.00 |
| Q1 2015 | +13,933 | New Buy | 13,933 | $42.92 |
| Q2 2015 | +14,167 | Add 101.68% | 28,100 | $46.23 |
| Q3 2015 | +202 | Add 0.72% | 28,302 | $45.16 |
| Q4 2015 | -1,881 | Reduce 6.65% | 26,421 | $51.47 |
| Q1 2016 | +3,447 | Add 13.05% | 29,868 | $53.40 |
| Q2 2016 | +36,555 | Add 122.39% | 66,423 | $55.40 |
| Q3 2016 | +3,078 | Add 4.63% | 69,501 | $48.27 |
| Q4 2016 | -34,578 | Reduce 49.75% | 34,923 | $52.09 |
| Q1 2017 | -17,510 | Reduce 50.14% | 17,413 | $55.53 |
| Q2 2017 | -17,413 | Sold Out | 17,413 | $0.00 |
| Q2 2018 | +49,371 | New Buy | 49,371 | $38.38 |
| Q3 2018 | -39,443 | Reduce 79.89% | 9,928 | $37.87 |
| Q4 2018 | -9,928 | Sold Out | 9,928 | $0.00 |
| Q3 2019 | +7,106 | New Buy | 7,106 | $34.76 |
| Q4 2019 | +4,817 | Add 67.79% | 11,923 | $40.51 |
| Q1 2020 | +125,342 | Add 1051.26% | 137,265 | $36.48 |
| Q2 2020 | +247,001 | Add 179.94% | 384,266 | $37.07 |
| Q3 2020 | +89,767 | Add 23.36% | 474,033 | $35.85 |
| Q4 2020 | -74,296 | Reduce 15.67% | 399,737 | $34.87 |
| Q1 2021 | -298,900 | Reduce 74.77% | 100,837 | $43.59 |
| Q2 2021 | -59,110 | Reduce 58.62% | 41,727 | $52.10 |
| Q3 2021 | -3,376 | Reduce 8.09% | 38,351 | $56.11 |
| Q4 2021 | +12,560 | Add 32.75% | 50,911 | $60.65 |
| Q1 2022 | +6,834 | Add 13.42% | 57,745 | $52.94 |
| Q2 2022 | +4,536 | Add 7.86% | 62,281 | $56.57 |
| Q3 2022 | +17,040 | Add 27.36% | 79,321 | $49.84 |
| Q4 2022 | -5,649 | Reduce 7.12% | 73,672 | $62.60 |
| Q1 2023 | -15,059 | Reduce 20.44% | 58,613 | $62.28 |
| Q2 2023 | -9,820 | Reduce 16.75% | 48,793 | $59.43 |
| Q3 2023 | -552 | Reduce 1.13% | 48,241 | $57.19 |
| Q4 2023 | -10,467 | Reduce 21.70% | 37,774 | $61.22 |
| Q1 2024 | -4,344 | Reduce 11.50% | 33,430 | $72.56 |
| Q2 2024 | -1,027 | Reduce 3.07% | 32,403 | $68.85 |
| Q3 2024 | -1,767 | Reduce 5.45% | 30,636 | $71.13 |
| Q4 2024 | -3,780 | Reduce 12.34% | 26,856 | $77.63 |
| Q1 2025 | +3,200 | Add 11.92% | 30,056 | $85.12 |
| Q2 2025 | -9,028 | Reduce 30.04% | 21,028 | $79.85 |
| Q3 2025 | +3,088 | Add 14.69% | 24,116 | $61.89 |
Cliff Asness's Prestige Consumer Healthcare Investment FAQs
Cliff Asness first purchased Prestige Consumer Healthcare Inc. (PBH) in Q4 2012, acquiring 239,142 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Prestige Consumer Healthcare Inc. (PBH) for 52 quarters since Q4 2012. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Prestige Consumer Healthcare Inc. (PBH) was in Q2 2020, adding 384,266 shares worth $14.24 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 24,116 shares of Prestige Consumer Healthcare Inc. (PBH), valued at approximately $1.49 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Prestige Consumer Healthcare Inc. (PBH) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Prestige Consumer Healthcare Inc. (PBH) was 474,033 shares, as reported at the end of Q3 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.